Promotion

IFN-alpha/beta R2, Human (HEK293, hFc)

IFN-alpha/beta R2, Human (HEK293, hFc)
SKU
MEXHY-P74860-10UG
Packaging Unit
10 μg
Manufacturer
MedChemExpress

Availability: loading...
Price is loading...

Don’t miss this promotion: enjoy a 20% discount on all recombinant proteins for our supplier MedChem Express until December 31, 2025. These special prices are already discounted – no additional discounts can be applied during the promotion period.

Product Description: IFN-alpha/beta R2, one of the subunit of IFN-α/β receptor, is a type I IFN receptor. IFN-alpha/beta R2 forms the heterodimeric receptor with IFNAR1, and binds to type I IFNs[1]. IFN-alpha/beta R2 also interacts with JAK1 and leads to tyrosine phosphorylation of the IFNARs and STAT proteins[2]. Upon activation by these IFNs, IFNAR1 and IFN-alpha/beta R2 undergo a conformational change to promote a cascade of downstream signaling events, including the phosphorylation of Tyk2 and JAK1, STAT1 and STAT2[3]. IFN-alpha/beta R2 Protein, Human (HEK293, hFc) is a recombinant human IFN-alpha/beta R2 (I27-K243) with C-terminal hFc tag, which is produced in HEK293 cells.

Formula: 3455(Gene_ID)P48551-1 (I27-K243)(Accession)

References: [1]Zanin N, et al. Interferon Receptor Trafficking and Signaling: Journey to the Cross Roads. Front Immunol. 2021 Jan 20;11:615603./[2]Shemesh M, et al. IFNAR1 and IFNAR2 play distinct roles in initiating type I interferon-induced JAK-STAT signaling and activating STATs. Sci Signal. 2021 Nov 23;14(710):eabe4627. /[3]Jun Zou, et al. Chapter 7 - Antiviral Immunity: Origin and Evolution in Vertebrates. The Evolution of the Immune System. 2016,Pages 173-204./[4]Pogue SL, et al. The receptor for type I IFNs is highly expressed on peripheral blood B cells and monocytes and mediates a distinct profile of differentiation and activation of these cells. J Interferon Cytokine Res. 2004 Feb;24(2):131-9./[5]Duncan CJ, et al. Human IFNAR2 deficiency: Lessons for antiviral immunity. Sci Transl Med. 2015 Sep 30;7(307):307ra154./[6]Hurtado-Guerrero I, et al. Immunomodulatory and Antiproliferative Activities of Recombinant Soluble IFNAR2 without IFN-β Mediation. J Clin Med. 2020 Mar 31;9(4):959.

Molecular Weight: 65-75 kDa

Compound Purity: 96.0
More Information
SKU MEXHY-P74860-10UG
Manufacturer MedChemExpress
Manufacturer SKU HY-P74860-10UG
Package Unit 10 μg
Quantity Unit STK
Product information (PDF)
×
MSDS (PDF)
×